Monoclonal Antibodies Market - Forecast(2020 - 2025)
Monoclonal Antibodies Market Overview: According to Cancer Research UK, around 17 million new cases of cancer and 9.6 million mortality incidences were recorded globally in 2018. [1] As per this statistic, the cancer threat is increasing rapidly throughout the world and safer medical treatment is being sought out over more conventional methods. Antibody vaccines effectively induce the desired medication with comparatively higher rates of success, leading to development of monoclonal antibodies (mAbs), which target a specific area or cell. Designed in laboratories with an aim to trigger the natural immune system and destroy cancer causing cells, monoclonal antibodies are a flagship innovation in the medical sector approved by the U.S. Food and Drug Administration (FDA) as an effective measure for cancer treatment. Potential benefits of monoclonal antibodies include detecting and killing abnormal cells directly, inhibiting cancer cell growth, and delivering radioac...